Hide Board Information

Show Board Information

CytomX Therapeutics Inc. CTMX

Board Mod: Add me as mod

Asst Mods:

Last Post: 01/06/2023 4:37:32 PM

Board Marks: 0

Posts Today: 0

Board Views Today: 3

CytomX Therapeutics Inc. (NASDAQ: CTMX) Stock Message Board

1. CTMX Company Profile

    

2. CTMX Time & Sales

    

3. CTMX Recent News

    

4. CTMX Filings

    

5. CTMX Financials

    

6. CTMX Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

3	$CTMX 40% v51,2M c2.52 f66,084M H2.98 ML1.33	znewcar1	01/06/2023 4:37:32 PM
2	$CTMX 32% v42,4M c1.60 f66,1M H1.68	znewcar1	11/17/2022 11:02:24 PM
1	EMERGING PARADIGMS IN TREATMENT OF MELANOMA! CTMX	AviseAnalytics	01/26/2022 7:48:54 AM

Recent Articles

• PolyPid Welcomes Dr. Nurit Tweezer-Zaks as CMO in 2025
• AssetMark Launches Enhanced SDBA Solution for Advisors
• Bayer Collaborates with Kumquat to Tackle KRAS Mutations
• Market Anticipation Grows for Key Economic Indicators Ahead
• Team Ontario Dominates at the U23 3x3 National Championships
• Rising Stagflation Concerns: Navigating Economic Uncertainty
• Enhancing Customer Experiences through AI with Sendbird and AWS
• The Impact of CPI on Gold Prices and Currency Movements
• Kevin O'Leary's Fresh Perspective on Crypto and Investment Wisdom
• Brodsky & Smith Highlights Investigations for Key Companies
• Leap Partners Enhances M&A Strategy with Midaxo Solutions
• Exploring Top Stocks: What's Hot with Investors Today?
• AgEagle Aerial Systems Launches Innovative RedEdge-P Green Camera
• Intensity Therapeutics Achieves Nasdaq Compliance for Equity
• ReTo Eco-Solutions Forges Stronger Ties with Global Clients
• Orchestra BioMed Achieves Significant Growth and Milestones
• Avant Technologies and Ainnova Tech Set New Path for Patient Recruitment
• IM Cannabis Shows Resilience with Solid Q2 2025 Results
• Baylin Technologies Secures $735K Order for Genesis Amplifiers
• Biotricity Inc. Set for a Strategic Business Update Call Soon
• RMX Industries Secures New Order from Army, Boosting Future Prospects
• Aardvark Therapeutics Reveals Promising Weight Loss Data for ARD-201
• iQSTEL's Revenue Surge: Path to $1 Billion by 2027
• electroCore Welcomes Kelly Benning as SVP to Enhance Consumer Wellness
• Tahiti Village Resort Enhances Guest Experience with Renovations
• Monopar Therapeutics Shares 2025 Financial Results and Updates
• Monopar Therapeutics' Q2 Financials and Major Developments
• ReTo Eco-Solutions Expands Global Reach with New Line
• The Stepping Stones Group Celebrates Decade of Growth Success
• Taysha Gene Therapies: Q2 2025 Financial Overview and Insights
• Silexion Therapeutics' Q2 2025 Performance and Growth Insights
• Citrin Cooperman's Strategic Acquisition to Boost Services
• Xeriant Launches Innovative Production Run for NEXBOARD Panels
• Newton Golf Company Set to Discuss Q2 2025 Financial Results
• Trend Micro Introduces Innovative AI-Driven Security Solutions
• Aprea Therapeutics Showcases Promising Clinical Advancements
• Introducing Project Pearl: A Bespoke Defender 110 Experience
• PMB Expands Healthcare Real Estate Team for Future Growth
• Century Global Commodities Reports Financial Results for Q1 2025
• Nanox Imaging Q2 2025 Results Show Strong Revenue Growth
• Ginkgo Bioworks Welcomes Brian O'Sullivan to Drive Growth
• Digs Dog Care Revolutionizes Pet Services with Premium Care
• Grace Therapeutics Updates on GTx-104 and Q1 Financials
• Genius Group Pursues New Opportunities with Asian Listing
• Revolutionary Tango Belt Launches to Safeguard Seniors from Falls
• Daxor Corporation Celebrates Nasdaq Closing Bell Ceremony Replay
• Electrosoft Celebrates 10th Inc. 5000 Recognition for Growth
• ProPhase Labs Secures New Patent for Cancer Risk Assessment Innovation
• Coya Therapeutics Discusses Q2 Financials and Future Plans
• OptimumBank Holdings, Inc. Reveals Earnings and Growth Strategy